ADDRESSING SAC REGRESSION FACTORS WITH Endurant II/IIs

Endurant™ II/IIs AAA stent graft has demonstrated low type I and type II endoleaks in broad patient anatomies.3,4 With:

  • Accurate placement and controlled deployment5
  • Continuous seal, fixation, and graft conformability5
  • Durable hemostatic barrier and resistance against type II endoleaks6

Play Video Er wordt nu een video gestart - Video thumbnail

See the features and benefits of the Endurant II/IIs system in action.

Display transcript

EVAR SUCCESS

Display Transcript

CLINICAL EVIDENCE  VQI Data

Latest data suggest aneurysm sac regression is associated with better long-term outcomes.2

Cohort that demonstrated sac regression at one year had significantly better outcomes than stable and expanding sac cohorts.

Graph depicting sac regression at 12 years compared to stable and expanding sac cohorts

Endurant data

Endurant demonstrates consistent and high sac regression rates across straightforward and complex anatomies.

Endurant Clinical Data
Graph depicting 5-year sac regression rate

A NEW
PARADIGM SHIFT

Hear the physician’s thoughts on aneurysm sac regression post-EVAR.
Watch the on demand webcast*
 
  • Moderator : Prof. dr. Jean-Pierre Becquemin, vascular surgeon, Hopital privé Paul D’Egine, Paris, France
  • Prof. dr. Hence Verhagen, vascular surgeon, Erasmus MC, Rotterdam, The Netherlands
  • Prof. dr. Michel Reijnen, vascular surgeon,  Rijnstate, Arnhem, The Netherlands
  • Dr. Apostolos Tassiopoulos, vascular surgeon, Stony Brook University, NY, USA

Webinar On Demand: Sac Regression and EVAR - A new paradigm shift

* This online on demand webcast has been accredited (ID 390100) by:

  • the NVVC (Nederlandse Vereniging voor Cardiologie) for 2 points. Valid until 19 February, 2022;
  • the NIV (Nederlandse Internisten Vereniging) for 2 points. Valid until 15 March, 2022;
  • the NVVH (Nederlandse Vereniging Voor Heelkunde) for 2 points. Valid until 22 March, 2022;
  • the NVVR (Nederlandse Vereniging voor Radiologie) for 2 points. Valid until 12 April, 2022.

Display Transcript

CHALLENGING EVAR PROCEDURE VIDEO CASE STUDY 

Interested to learn more?

Interested in learning more about Aortic educational content for therapies of your interest?

Visit our eLearning platform

Learn more

References

1

Ahn SS, Rutherford RB, Johnston KW, et al. Reporting standards for infrarenal endovascular abdominal aortic aneurysm repair. Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg. February 1997;25(2):405-410.

2

O’Donnell TFX, Deery SE, Boitano LT, et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. February 2019;69(2):414-422.

3

Singh MJ, Fairman R, Anain P, et al. Final Results of the Endurant Stent Graft System in the United States regulatory trial. J Vasc Surg. July 2016;64(1):55-62.

4

Teijink JAW, Power AH, Böckler D, et al. Editor's Choice - Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry. Eur J Vasc Endovasc Surg. August 2019;58(2):175-181.

5

Medtronic data on file.

6

Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234-243.